We are live on ! Find out more
DCMM

DG Capital Management (Massachusetts) Portfolio holdings

AUM $102M
1-Year Est. Return 29.14%
This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
10 Year Est. Return
AUM
$165M
AUM Growth
Cap. Flow
+$165M
Cap. Flow %
99.97%
Top 10 Hldgs %
27.59%
Holding
56
New
56
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.36M
2
GILD icon
Gilead Sciences
GILD
+$5.44M
3
C icon
Citigroup
C
+$4.4M
4
ABBV icon
AbbVie
ABBV
+$4.24M
5
CB icon
Chubb
CB
+$4.18M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 27.87%
2 Financials 20.48%
3 Communication Services 9.49%
4 Consumer Discretionary 9.28%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$29.9B
$6.4M 3.88%
+29,755
New +$6.36M
GILD icon
2
Gilead Sciences
GILD
$161B
$5.35M 3.24%
+104,300
New +$5.44M
C icon
3
Citigroup
C
$222B
$4.39M 2.66%
+91,495
New +$4.4M
AIG icon
4
American International
AIG
$41.9B
$4.35M 2.64%
+97,375
New +$4.18M
PARA
5
DELISTED
Paramount Global Class B
PARA
$4.34M 2.63%
+88,850
New +$4.06M
MA icon
6
Mastercard
MA
$477B
$4.27M 2.59%
+74,350
New +$4.13M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$3.9T
$4.22M 2.56%
+192,519
New +$4.07M
CB icon
8
Chubb
CB
$140B
$4.18M 2.53%
+46,680
New +$4.18M
ABBV icon
9
AbbVie
ABBV
$458B
$4.01M 2.43%
+96,990
New +$4.24M
NVS icon
10
Novartis
NVS
$295B
$4M 2.43%
+63,149
New +$4.11M
MJN
11
DELISTED
Mead Johnson Nutrition Company
MJN
$3.74M 2.27%
+47,185
New +$3.78M
ACGL icon
12
Arch Capital
ACGL
$36.1B
$3.67M 2.23%
+214,230
New +$3.73M
DAL icon
13
Delta Air Lines
DAL
$55.9B
$3.67M 2.22%
+196,095
New +$3.4M
VIAB
14
DELISTED
Viacom Inc. Class B
VIAB
$3.64M 2.21%
+53,555
New +$3.56M
AWH
15
DELISTED
Allied World Assurance Co Hld Lt
AWH
$3.62M 2.19%
+118,710
New +$3.62M
LVS icon
16
Las Vegas Sands
LVS
$30.5B
$3.62M 2.19%
+68,289
New +$3.82M
NWSA
17
DELISTED
NEWS CORPORATION CL-A
NWSA
$3.57M 2.17%
+109,675
New +$3.49M
V icon
18
Visa
V
$677B
$3.55M 2.15%
+77,780
New +$3.4M
APC
19
DELISTED
Anadarko Petroleum
APC
$3.54M 2.14%
+41,165
New +$3.54M
CELG
20
DELISTED
Celgene Corp
CELG
$3.53M 2.14%
+60,280
New +$3.63M
SNY icon
21
Sanofi
SNY
$104B
$3.52M 2.13%
+68,290
New +$3.64M
UAL icon
22
United Airlines
UAL
$38.4B
$3.48M 2.11%
+111,330
New +$3.54M
AMZN icon
23
Amazon
AMZN
$2.5T
$3.46M 2.1%
+249,400
New +$3.32M
TWX
24
DELISTED
Time Warner Inc
TWX
$3.46M 2.1%
+62,392
New +$3.53M
BBY icon
25
Best Buy
BBY
$18B
$3.39M 2.06%
+124,100
New +$3.2M

Similar funds

DG Capital Management (Massachusetts)'s Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for DG Capital Management (Massachusetts), which disclosed 56 positions worth $165M. Its ten largest holdings account for 28% of the portfolio.

Its largest position is Biogen: 29,755 shares worth $6.4M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, followed by Financials and Communication Services.

  • DG Capital Management (Massachusetts)'s largest Q2 2013 buy was Biogen: 29,755 shares worth $6.4M.
  • DG Capital Management (Massachusetts)'s ten largest holdings make up 28% of its $165M portfolio in Q2 2013.
  • DG Capital Management (Massachusetts) disclosed 56 positions in Q2 2013, its first 13F filing on record.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q2 2013, filed 5 Aug 2013.